C29H35ClN6O4S2
Neat
631.21
3-Hydroxy-avatrombopag; 1290121-42-4; WH4VBD5V22; UNII-WH4VBD5V22; Avatrombopag metabolite (3-hydroxy-avatrombopag); 1-(5-((4-(4-Chloro-2-thienyl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)-3-hydroxy-2-pyridyl)piperidine-4-carboxylic acid; 1-(5-((4-(4-Chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)-3-hydroxypyridin-2-yl)piperidine-4-carboxylic acid; 4-Piperidinecarboxylic acid and 1-(5-(((4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl)amino)carbonyl)-3-hydroxy-2-pyridinyl)-
1-[5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1 and 3-thiazol-2-yl]carbamoyl]-3-hydroxy-2-pyridinyl]piperidine-4-carboxylic acid
InChI=1S/C29H35ClN6O4S2/c30-20-15-23(41-17-20)24-27(36-12-10-34(11-13-36)21-4-2-1-3-5-21)42-29(32-24)33-26(38)19-14-22(37)25(31-16-19)35-8-6-18(7-9-35)28(39)40/h14-18,21,37H,1-13H2,(H,39,40)(H,32,33,38)